MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS

间日疟原虫表面抗原的分子分析

基本信息

  • 批准号:
    8172324
  • 负责人:
  • 金额:
    $ 5.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long-term objective of this research is to provide fundamental molecular biological and immunobiological information tosupport the development of a blood-stage vaccine against Plasmodium vivax, one of the two most prevalent species of human malaria. This research is also relevant for increasing the understanding of the biology of P. falciparum, the other major species of human malaria. The related non-human primate malarias P. cynomolgi, P. coatneyi and P. knowlesi, which infected rhesus monkeys, are excellent models for these investigations. This project entails the characterization of several Plasmodium merozoite proteins and the genes encoding them, with emphasis on molecules that 1) have an apparent direct or indirect function in the receptor mediated processes of merozoite invasion of erythrocytes, and 2) are likely to have a role in affecting the immunobiological relationship between P. vivax and humans by stimulating anti-P. vivax immune responses. The coordinated use of in-vitro merozoite invasion and attachment assays, immunoelectron microscopy, gene knockout technologies, defined antibody and recombinant DNA reagents, and the use of the simian malaria models, aid in the precise determination and clarification of the location(s), function, structure and possible interactive relationships of the merozoite proteins under investigation. This year, our report on the identification of the normocyte binding protein family in P. knowlesi was published, and manuscripts on the discovery of a PkNBP erythrocyte binding domain, the Pv and Pk RhopH complex, the 11 member Pv MSP3 family, and P. cynomolgi PHIST protein and family are under review for submission. A manuscript defining a novel merozoite apical protein (MAP) is being prepared. This year, extensive transcriptome and proteome data have also been generated and analyzes are underway in preparation for manuscripts and the design of new directions. Further, three reviews have been published and support provided for a study on chimeric vaccine development and testing.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 这项研究的长期目标是提供基本的分子生物学和免疫生物学信息,以支持针对间日疟原虫(人类疟疾的两种最流行的物种之一)的血液阶段疫苗的开发。这项研究还有助于加深对恶性疟原虫生物学的了解,恶性疟原虫是人类疟疾的另一个主要物种。感染恒河猴的相关非人灵长类疟疾P. cynomolgi,P. coatneyi和P. knowlesi是这些研究的极好模型。该项目需要表征几种疟原虫裂殖子蛋白和编码它们的基因,重点是1)在裂殖子侵入红细胞的受体介导的过程中具有明显的直接或间接功能的分子,和2)可能通过刺激抗间日疟原虫免疫应答而在影响间日疟原虫和人类之间的免疫生物学关系中具有作用的分子。 协调使用体外裂殖子侵入和附着测定、免疫电子显微术、基因敲除技术、确定的抗体和重组DNA试剂以及使用猿猴疟疾模型,有助于精确测定和澄清所研究的裂殖子蛋白的位置、功能、结构和可能的相互关系。今年,我们发表了关于在P. knowlesi中鉴定正常细胞结合蛋白家族的报告,并且正在审查提交关于发现PkNBP红细胞结合结构域、Pv和Pk RhopH复合物、11个成员的Pv MSP 3家族以及P. cynomolgi PHIST蛋白和家族的手稿。一个定义新的裂殖子顶端蛋白(MAP)的手稿正在准备中。 今年,还生成了大量的转录组和蛋白质组数据,并正在进行分析,为手稿和新方向的设计做准备。此外,已经发表了三篇综述,并为嵌合疫苗开发和测试的研究提供了支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY R GALINSKI其他文献

MARY R GALINSKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY R GALINSKI', 18)}}的其他基金

Integrated Approach to Host-Pathogen Interactions
宿主-病原体相互作用的综合方法
  • 批准号:
    8564414
  • 财政年份:
    2012
  • 资助金额:
    $ 5.48万
  • 项目类别:
Plasmodium cynomolgi as a model for P. vivax.
食蟹猴疟原虫作为间日疟原虫的模型。
  • 批准号:
    8290557
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
RBL Binding Domain Malaria Candidate Vaccines
RBL 结合域疟疾候选疫苗
  • 批准号:
    8104854
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
网状细胞结合样 (RBL) 蛋白作为新一代疟疾疫苗
  • 批准号:
    8357495
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
间日疟原虫表面抗原的分子分析
  • 批准号:
    8357395
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
RBL Binding Domain Malaria Candidate Vaccines
RBL 结合域疟疾候选疫苗
  • 批准号:
    8231986
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
疟疾抗原变异的分子基础
  • 批准号:
    8357390
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
Plasmodium cynomolgi as a model for P. vivax.
食蟹猴疟原虫作为间日疟原虫的模型。
  • 批准号:
    8177389
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENS
间日疟原虫 MSP-3 和 MSP-9 作为疫苗免疫原
  • 批准号:
    8172356
  • 财政年份:
    2010
  • 资助金额:
    $ 5.48万
  • 项目类别:
RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
网状细胞结合样 (RBL) 蛋白作为新一代疟疾疫苗
  • 批准号:
    8172457
  • 财政年份:
    2010
  • 资助金额:
    $ 5.48万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了